Da: Ammareal, Morangis, Francia
EUR 5,84
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Très bon. Ancien livre de bibliothèque. Légères traces d'usure sur la couverture. Salissures sur la tranche. Edition 2004. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Slight signs of wear on the cover. Stains on the edge. Edition 2004. Ammareal gives back up to 15% of this item's net price to charity organizations.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Condizione: New. pp. 376 1st Edition.
EUR 68,83
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. pp. 376.
EUR 68,43
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. pp. 376.
Editore: Humana Press, Totowa, NJ, 2004., 2004
Da: My Dead Aunt's Books, Hyattsville, MD, U.S.A.
Condizione: Very Good. First ed. in pristine condition; pages immaculate and unmarked; bindings tight; glossy pictorial boards show minimal shelf wear despite absence of d.j.s; b & w ill. Vol. I, "Detection, Genotypes and Characterization"has 349 p and Vol. II, "Immunology, Model Systems and Clinical Studies" has 572 p. Inserts comprise a letter to former owner, a physician, asking him to review the volumes forr the Clinical Chemistry journal, and forms for assignment of copyright for the reviews.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Prima edizione
EUR 144,07
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MJCJ. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 30. Weight in Grams: 790. . 2010. 1st ed. Softcover of orig. ed. 2004. Paperback. . . . .
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 166,94
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: preigu, Osnabrück, Germania
EUR 104,20
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Hepatitis B and D Protocols | Volume 2: Immunology, Model Systems, and Clinical Studies | Robert K. Hamatake (u. a.) | Taschenbuch | Methods in Molecular Medicine | xxiii | Englisch | 2010 | Humana | EAN 9781617373633 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 169,43
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Condizione: New. pp. 598.
Da: Revaluation Books, Exeter, Regno Unito
EUR 172,13
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 572 pages. 9.00x6.00x1.25 inches. In Stock.
Lingua: Inglese
Editore: Springer, 2004
Da: Books in my Basket, New Delhi, India
EUR 170,55
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. ISBN:9781588291080.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 179,35
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Condizione: New. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MJCJ. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 30. Weight in Grams: 790. . 2010. 1st ed. Softcover of orig. ed. 2004. Paperback. . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: Springer, 2004
Da: Books in my Basket, New Delhi, India
EUR 182,74
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. ISBN:9781588291059.
EUR 197,95
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. This title discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV). It reviews research techniques used in the study of HBV and HDV and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 376 pages, 109 black & white illustrations, 1 colour illustrations, biography. BIC Classification: MJJ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 229 x 152 x 25. Weight in Grams: 725. . 2004. Hardback. . . . .
EUR 200,51
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. This work discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV) in two volumes; reviews research techniques used in the study of HBV and HDV; and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MMFM. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 32. Weight in Grams: 1162. . 2004. Hardback. . . . .
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 193,77
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Condizione: New. pp. 600 1st Edition.
Da: Revaluation Books, Exeter, Regno Unito
EUR 239,31
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 600 pages. 9.25x6.25x0.75 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 241,63
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 600 pages. 9.00x6.00x1.25 inches. In Stock.
Condizione: New. This title discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV). It reviews research techniques used in the study of HBV and HDV and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 376 pages, 109 black & white illustrations, 1 colour illustrations, biography. BIC Classification: MJJ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 229 x 152 x 25. Weight in Grams: 725. . 2004. Hardback. . . . . Books ship from the US and Ireland.
Condizione: New. This work discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV) in two volumes; reviews research techniques used in the study of HBV and HDV; and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MMFM. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 32. Weight in Grams: 1162. . 2004. Hardback. . . . . Books ship from the US and Ireland.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 94,25
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 117,69
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions. 596 pp. Englisch.
Lingua: Inglese
Editore: Humana Press, Humana Nov 2010, 2010
ISBN 10: 161737363X ISBN 13: 9781617373633
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 117,69
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 596 pp. Englisch.